S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
AMEX
Palatin Technologies Inc New (PTN)
Palatin Technologies Inc New (PTN) News

PTN

Palatin Technologies (PTN)

Palatin Technologies Inc New

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:PTN

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
05/09/2024	6:30AM	PR Newswire (US)	Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024	AMEX:PTN	Palatin Technologies Inc New
05/02/2024	6:30AM	PR Newswire (US)	Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity	AMEX:PTN	Palatin Technologies Inc New
04/30/2024	6:30AM	PR Newswire (US)	Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024	AMEX:PTN	Palatin Technologies Inc New
04/08/2024	6:30AM	PR Newswire (US)	Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024	AMEX:PTN	Palatin Technologies Inc New
03/07/2024	4:02PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:PTN	Palatin Technologies Inc New
03/04/2024	11:57AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	AMEX:PTN	Palatin Technologies Inc New
02/28/2024	6:30AM	PR Newswire (US)	Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)	AMEX:PTN	Palatin Technologies Inc New
02/15/2024	8:00AM	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:PTN	Palatin Technologies Inc New
02/15/2024	6:30AM	PR Newswire (US)	Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	AMEX:PTN	Palatin Technologies Inc New
02/14/2024	3:17PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:PTN	Palatin Technologies Inc New
02/14/2024	1:55PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	AMEX:PTN	Palatin Technologies Inc New
02/09/2024	6:30AM	PR Newswire (US)	Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024	AMEX:PTN	Palatin Technologies Inc New
02/05/2024	6:30AM	PR Newswire (US)	Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)	AMEX:PTN	Palatin Technologies Inc New
02/01/2024	4:16PM	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:PTN	Palatin Technologies Inc New
02/01/2024	3:00PM	PR Newswire (US)	Palatin Announces Closing of $10 Million Registered Direct Offering	AMEX:PTN	Palatin Technologies Inc New
02/01/2024	8:40AM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:PTN	Palatin Technologies Inc New
01/30/2024	7:00AM	PR Newswire (US)	Palatin Announces $10 Million Registered Direct Offering	AMEX:PTN	Palatin Technologies Inc New
01/08/2024	9:33AM	PR Newswire (US)	Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024	AMEX:PTN	Palatin Technologies Inc New
01/03/2024	7:00AM	Business Wire	Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.	AMEX:PTN	Palatin Technologies Inc New
12/20/2023	8:00AM	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:PTN	Palatin Technologies Inc New
12/20/2023	6:30AM	PR Newswire (US)	Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million	AMEX:PTN	Palatin Technologies Inc New
12/18/2023	3:45PM	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:PTN	Palatin Technologies Inc New
12/18/2023	3:15PM	PR Newswire (US)	Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American	AMEX:PTN	Palatin Technologies Inc New
12/17/2023	11:15PM	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:PTN	Palatin Technologies Inc New
12/15/2023	3:03PM	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:PTN	Palatin Technologies Inc New
12/08/2023	4:30PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:PTN	Palatin Technologies Inc New
12/06/2023	4:02PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:PTN	Palatin Technologies Inc New
12/06/2023	1:25PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	AMEX:PTN	Palatin Technologies Inc New
12/04/2023	4:00PM	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	AMEX:PTN	Palatin Technologies Inc New
12/01/2023	2:52PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	AMEX:PTN	Palatin Technologies Inc New

Showing the most relevant articles for your search:AMEX:PTN

1 2 3 4 5 6 7 8 9 10 Next >>

Emergent Health (PK)

Music Licensing (PK)

TransCode Therapeutics

ProText Mobility (PK)

GNCC Capital (CE)

NaturalShrimp (QB)

Yuenglings Ice Cream (PK)

Indoor Harvest (PK)

Brookmount Explorations (PK)

Clean Vision (QB)

Cann American (CE)

Elite Pharmaceuticals (QB)

Net Savings Link (PK)

Decentral Life (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions